U.S. Senate’s Cannabis Administration and Opportunity Act Clarifies How Federal Government May Regulate Marijuana but Leaves Unanswered Questions July 21, 2021 Ian Stewart Federal 3 Comments The much-anticipated proposed Senate bill that would legalize marijuana on the federal level was made public on July 14, 2021, by its lead sponsor, Senate Majority Leader Charles Schumer (D-New York). Called the Cannabis Administration and Opportunity Act, it removes… Read More→
Call for National Lab Testing Standards February 26, 2020 Reggie Snyder Lab Testing, News & Insights, Science and Technology, Spotlight, Standards and Certification 0 Comments Medical and Recreational Marijuana: Legal Issues, Operational Challenges and Regulatory Hurdles That Marijuana-Related Businesses Frequently Encounter PART 3 of 6: An Overview of How the Lack of National Standards for Laboratory Tests of Marijuana Products Affects the Public Health and… Read More→
Cannabis Smoke: The Good, the Bad and the Ugly September 20, 2019 Rob Meagher Policy & Legal 0 Comments By Daniel Shortt, Attorney at Harris Bricken The last few days we’ve seen a flurry of activity related to smokable cannabis products. It’s been tough to keep track of everything that’s gone on, so today I’m going to take a… Read More→
Cannabis Smoke: The Good, the Bad and the Ugly September 19, 2019 AggregatedNews Policy & Legal 0 Comments By Daniel Shortt, Attorney at Harris Bricken The last few days we’ve seen a flurry of activity related to smokable cannabis products. It’s been tough to keep track of everything that’s gone on, so today I’m going to take a… Read More→
Four Important Considerations for Any Hemp CBD Company August 27, 2019 AggregatedNews Policy & Legal 0 Comments By Griffen Thorne, Attorney @ Harris Bricken State governments and the federal Food and Drug Administration (“FDA”) take wildly different approaches when it comes to Hemp-derived cannabidiol (“Hemp CBD”), and for the most part, the ball is still in the… Read More→
Big Pharma is Coming for the Cannabis Industry January 5, 2019 John Taenzler Medical Marijuana, Science and Technology 0 Comments In a recent double-blinded study [1] examining the attitudes of pain specialists and oncologists toward the use of MMJ, only 38% of these physicians in the USA are recommending MMJ to their patients for treating the symptoms of their disease and/or… Read More→
The Federal Government has acknowledged a patent on a cannabis based pharmaceutical as a legitimate and useful medicine June 29, 2018 Mark Goldfogel Op-Ed, Opinions 1 Comment G.W. Pharmaceuticals accomplished a feat that is about to change the course of history. They achieved drug approval for a plant-based medicine related to cannabis for treatment of certain conditions in children! This doesn’t apply only to states that have… Read More→
The FDA Just Approved the First-Ever Cannabis Based Drug in the U.S. June 26, 2018 AggregatedNews Policy & Legal, Science and Technology 0 Comments The Food and Drug Administration (FDA) for the first time approved a drug directly derived from cannabis on Monday, Epidiolex, developed by the British GW Pharmaceuticals. Although several states have legalized the medical and recreational use of marijuana, the federal… Read More→